Important: DuoDote is approved in the United States and Canada. Supply in other countries is subject to local regulatory approval. Always follow the full Prescribing Information, including warnings on cardiovascular risk, heat injury, glaucoma and use in patients with lung or kidney disease.
Key features
- Two drugs in one auto-injector using the BinaJect® two-chamber system
- Delivers 2.1 mg atropine and 600 mg pralidoxime chloride sequentially
- Intramuscular injection for rapid use in the field
- U.S. FDA-approved for adults and paediatric patients weighing more than 41 kg (90 lb)
- NATO stock-numbered for military supply
- Not made with natural rubber latex
Specifications
| NSN / NDC | 6505-01-581-1327 / 11704-620-01 |
|---|---|
| Contents | 2.1 mg atropine in 0.7 mL + 600 mg pralidoxime chloride in 2 mL |
| Unit size | Length 145 mm, diameter 19 mm |
| Needle | 23 gauge, 21 mm |
| Packaging | 1 per box; 30 per shipper (286 × 213 × 210 mm, 2.3 kg) |
| Storage | 25 °C (excursions 15 – 30 °C); do not freeze; protect from light |
| Prescription | Required |
Specifications are provided by the manufacturer and may change without notice. Contact Overtech for the latest datasheet.





